The ascendancy of Viagra and its influence on the drug landscape presents a complicated question for investors. While the early sales figures were astounding, the exclusivity has expired, leading to a wave of off-brand https://idanson649468.azzablog.com/41823378/the-blue-pill-and-big-pharma-a-dangerous-opportunity